Clalit Launches 2026-2027 Winter Flu Vaccination Campaign

Clalit Health Services has initiated its annual influenza vaccination campaign for the 2026-2027 winter season, with shots becoming available starting next week. Initially, vaccinations will be administered at designated clinics, with a gradual expansion to all Clalit clinics nationwide as vaccine supplies arrive in batches throughout September and October.

Clalit has ordered over one million doses of the injectable flu vaccine and an additional 25,000 nasal spray doses for individuals aged two to 49. The phased arrival of vaccines means the campaign will commence with the first available doses to ensure early access, particularly for high-risk groups. Ronen Nodelman, Clalit's Deputy Director General, stated that the health fund is prepared for a large-scale campaign, building on last winter's nearly one million vaccinations, with approximately 55% of those aged 65 and above receiving the shot.

Sivi Sobel Revitalblatt, Head Nurse of Community Division and campaign director, emphasized the vaccine's effectiveness in reducing illness, complications, and hospitalizations, noting it can lower flu risk by 40-60%. Dr. Bat Sheva Gotzman, an infectious disease specialist, highlighted that influenza can increase the risk of heart attack and stroke, with potential cardiac events rising significantly in the week following infection. The vaccine's importance extends to mitigating these cardiovascular risks, especially for the elderly and those with chronic conditions.

Clalit recommends the flu vaccine for everyone six months and older, with particular emphasis on individuals with chronic illnesses, compromised immune systems, obesity, young children (six months to five years), adults 50 and over (especially 65+), pregnant and postpartum women, and residents of long-term care facilities. Clalit members with Moshlam insurance can also purchase Tamiflu at a 50% discount with a prescription. Information on vaccination centers and appointment booking is available on Clalit's website.